Zoetis Inc (ZTS)

52.01
0.99 1.94
NYSE : Health Care
Prev Close 51.02
Open 51.03
Day Low/High 50.95 / 52.12
52 Wk Low/High 38.26 / 52.64
Volume 3.97M
Avg Volume 3.24M
Exchange NYSE
Shares Outstanding 495.04M
Market Cap 25.62B
EPS 0.70
P/E Ratio 40.12
Div & Yield 0.38 (0.70%)

Latest News

Valeant's $1.5 Billion 'Capital Hole' -- and $31 Billion in Debt

Valeant's $1.5 Billion 'Capital Hole' -- and $31 Billion in Debt

It may not be possible for Valeant to wind down its massive debt as quickly as expected, say Deutsche Bank analysts.

Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole'

Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole'

It may not be possible for Valeant to wind down its massive debt as quickly as expected, say Deutsche Bank analysts.

Pet Pharma Is the Newest Growth Sector

Pet Pharma Is the Newest Growth Sector

Zoetis is selling a lineup of drugs for dogs, and that looks to mean big business.

Nervous Pooch? There's a Drug for That

Nervous Pooch? There's a Drug for That

Zoetis is not averse to a little noise as investors, analysts take notice.

Zoetis Remains Attractive Alternative Healthcare Investment

Zoetis Remains Attractive Alternative Healthcare Investment

Zoetis' valuation doesn't reflect opportunities from innovation, operational improvements, and capital allocation, according to one analyst.

Zoetis (ZTS) Stock is a New 'Buy', Aureus Asset Management CEO Firestone Tells CNBC

Zoetis (ZTS) Stock is a New 'Buy', Aureus Asset Management CEO Firestone Tells CNBC

Zoetis (ZTS) stock is a smart buy for investors as a result of its growing pet business, Aureus Asset Management CEO Karen Firestone said on CNBC.

'Mad Money' Lightning Round: Lockheed Martin Can Fly to $210

'Mad Money' Lightning Round: Lockheed Martin Can Fly to $210

Cramer says McCormick is up too much and he's not chasing Clayton Williams Energy.

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street

There are too many companies in just about every sector of this market, Cramer says.

Valeant's C-Suite Sees Another Shake-Up

Valeant's C-Suite Sees Another Shake-Up

Paul Herendeen, former CFO of Zoetis, will assume those duties as his new employer eyes divestitures.

Zoetis (ZTS) Stock Down, Appoints New CFO

Zoetis (ZTS) Stock Down, Appoints New CFO

Zoetis (ZTS) announced that Glenn David would be its new CFO effective immediately.

Valeant Shares Rise on New CFO Appointment

Valeant Shares Rise on New CFO Appointment

Shares of Valeant Pharmaceuticals were higher Monday on news that the company named a new CFO.

Jim Cramer: New Valeant CFO is 'Solid'

Jim Cramer: New Valeant CFO is 'Solid'

Valeant's new CFO Paul Herendeen is a 'solid' performer and a welcome addition to the beleaguered company, says Jim Cramer

Jim Cramer -- Valeant Investors Should Welcome a High-Quality CFO

Jim Cramer -- Valeant Investors Should Welcome a High-Quality CFO

Cramer said investors should be cheering the reported arrival of CFO Paul Herendeen at Valeant.

Morning Movers: PFE, VRX, VIAB, FL, UA

Morning Movers: PFE, VRX, VIAB, FL, UA

Pfizer agrees to acquire Medivation while Citi puts Foot Locker and Under Armour on the back-to-school shopping list.

Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy

Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy

A potential blockbuster drug deal is reportedly in the works.

Zoetis Announces Appointment Of Glenn David As Executive Vice President And Chief Financial Officer

Zoetis Announces Appointment Of Glenn David As Executive Vice President And Chief Financial Officer

Zoetis Inc. (NYSE:ZTS) today announced that Glenn David, Senior Vice President of Finance Operations, has been named Executive Vice President and Chief Financial Officer (CFO), and will assume responsibility for the...

Zoetis To Participate In The Morgan Stanley Global Healthcare Conference

Zoetis To Participate In The Morgan Stanley Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept.

Pets Are Big Business Now and These Stocks Are Behind the Trend

Pets Are Big Business Now and These Stocks Are Behind the Trend

TheStreet's Jim Cramer says the humanization of pets is a growing investment opportunity.

Pets Are Family Now and These Stocks Are Best in Show

Pets Are Family Now and These Stocks Are Best in Show

The humanization of pets has sent spending soaring, which has some pet-related stock seeing major benefits.

Zoetis Acquires Scandinavian Micro Biodevices To Extend Its Pipeline In Diagnostics For Veterinary Use

Zoetis Acquires Scandinavian Micro Biodevices To Extend Its Pipeline In Diagnostics For Veterinary Use

Zoetis Inc. (NYSE:ZTS) today announced that it has completed the purchase of Scandinavian Micro Biodevices, a pioneer in developing and manufacturing microfluidic "lab on a chip" diagnostic analyzers and tests for...

CMCSA, IDXX, ZTS: Jim Cramer's Views

CMCSA, IDXX, ZTS: Jim Cramer's Views

Cramer shares his views on the winners and losers of this earnings season. Comcast, Idexx Laboratories and Zoetis are among the stocks discussed.

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Cramer has seen enough in this earnings season to come to some conclusions on what's working and what isn't.

Cramer: Here's What to Embrace and What to Shun

Cramer: Here's What to Embrace and What to Shun

With enough of earnings season now under our belt, we check out the promising themes and the sectors to avoid.

Market Is on Right Track, UBS, Mizuho Analysts Assured CNBC

Market Is on Right Track, UBS, Mizuho Analysts Assured CNBC

UBS' Stephen Freedman and Mizuho's Steven Ricchiuto explained why investors should not be concerned about the recent downturn of the market on CNBC today.

Zoetis (ZTS) Stock Gains, Raises Outlook After Q2 Beat

Zoetis (ZTS) Stock Gains, Raises Outlook After Q2 Beat

Zoetis (ZTS) stock was trading higher pre-market as it boosted its outlook after reporting better-than-expected earnings and revenue for the second quarter.

Zoetis (ZTS): Today's Pre-Market Leader Stock

Zoetis (ZTS): Today's Pre-Market Leader Stock

Trade-Ideas LLC identified Zoetis (ZTS) as a pre-market leader candidate

Zoetis Reports Second Quarter 2016 Results

Zoetis Reports Second Quarter 2016 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2016 and increased its revenue and adjusted net income guidance for full year 2016.

What to Expect When Zoetis (ZTS) Reports Q2 Earnings

What to Expect When Zoetis (ZTS) Reports Q2 Earnings

Zoetis (ZTS) is expected to post 2016 second-quarter results before tomorrow's opening bell.